Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 1943年11月，新华医疗诞生于胶东抗日根据地，是我党我军早期创建的医疗器械生产企业。新华医疗于2002年在上海证券交易所上市(股票代码:600587)。中国医疗器械行业协会会长单位;中国医学装备协会副理事长单位;感染与控制技术专业委员会理事长单位;中国放射治疗产业技术创新战略联盟理事长单位;中国制药装备行业协会理事单位;中国医药设备工程协会理事单位。 新华医疗拥有国家认定企业技术中心，设有“博士后科研工作站”“山东省肿瘤治疗技术企业重点实验室”等多个省级技术研发平台，入选国务院国资委“科改示范企业”、中国制造业企业500强、中国企业专利500强、省“十强”产业集群领军企业。有泰山产业领军人才3人、省管企业杰出创新人才1人，承担、参与了国家重点研发项目20余项，获得省市级科技进步奖10余项。截至2023年10月，已起草国家标准40项，行业标准84项；授权专利3530项，其中发明专利240项，实用新型专利2670项；软件著作权登记234项。
Main Business 医疗器械、制药装备、医疗服务和医疗商贸四大业务板块
Legal Representative 王玉全
Top Executives
董事长：王玉全
董事：王玉全,张福泉,李孝利,周娟娟,王月永,赵小利
独立董事：姜丽勇,顾维军,潘爱玲,黎元
Top 5 Shareholder
Shareholder name Nature Holding Date
山东颐养健康产业发展集团有限公司流通A股28.91%30/09/2024
山东省国有资产投资控股有限公司流通A股4.15%30/09/2024
中国银行股份有限公司－华宝中证医疗交易型开放式指数证券投资基金流通A股2.69%30/09/2024
兴业银行股份有限公司－博时汇兴回报一年持有期灵活配置混合型证券投资基金流通A股2.20%30/09/2024
香港中央结算有限公司流通A股1.63%30/09/2024
Company Secretary 李财祥
Solicitors 北京市君致律师事务所
Auditors 天职国际会计师事务所（特殊普通合伙）
Tel No 0533-3587766
Fax No 0533-3587768
Website www.shinva.net
Email shinva@163.com
Company Address
Register: 山东省淄博市高新技术产业开发区新华医疗科技园
Office: 山东省淄博市高新技术产业开发区新华医疗科技园
Listing Date 27/09/2002
Shares Capital
Shares Capital: 606,677,919
Total A Share: 606,677,919
Listed A Share: 602,046,492
Non-tradable A Share: 4,631,427
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 1.430
DPS(RMB)* ¥ 0.500
NBV Per Share(RMB)* ¥ 15.682
Market Capitalization(RMB) 11.072B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.